Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital and NIHR Biomedical Research Centre London, London, United Kingdom.
Pediatr Crit Care Med. 2020 Nov;21(11):e1031-e1037. doi: 10.1097/PCC.0000000000002553.
Severe acute respiratory syndrome coronavirus 2 is a novel cause of organ dysfunction in children, presenting as either coronavirus disease 2019 with sepsis and/or respiratory failure or a hyperinflammatory shock syndrome. Clinicians must now consider these diagnoses when evaluating children for septic shock and sepsis-associated organ dysfunction. The Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-associated Organ Dysfunction in Children provide an appropriate framework for the early recognition and initial resuscitation of children with sepsis or septic shock caused by all pathogens, including severe acute respiratory syndrome coronavirus 2. However, the potential benefits of select adjunctive therapies may differ from non-coronavirus disease 2019 sepsis.
严重急性呼吸综合征冠状病毒 2 是儿童器官功能障碍的一种新病因,表现为 2019 年冠状病毒病伴有脓毒症和/或呼吸衰竭,或高炎症性休克综合征。临床医生在评估儿童脓毒性休克和与脓毒症相关的器官功能障碍时,现在必须考虑这些诊断。《拯救脓毒症运动:儿童脓毒症和脓毒症相关器官功能障碍管理国际指南》为所有病原体(包括严重急性呼吸综合征冠状病毒 2)引起的脓毒症或脓毒性休克儿童的早期识别和初始复苏提供了适当的框架。然而,某些辅助治疗的潜在益处可能与非 2019 年冠状病毒病的脓毒症不同。